T1 Mapping of the Gadolinium-Enhanced Myocardium: Adjustment for Factors Affecting Interpatient Comparison

被引:100
作者
Gai, Neville [1 ,2 ]
Turkbey, Evrim B. [1 ,2 ]
Nazarian, Saman [3 ]
van der Geest, Rob J. [4 ]
Liu, Chia-Ying [5 ]
Lima, Joao A. C. [3 ,5 ]
Bluemke, David A. [1 ,2 ,5 ]
机构
[1] NIH, Ctr Clin, Bethesda, MD 20892 USA
[2] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[4] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[5] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA
关键词
T-1; mapping; myocardial fibrosis; patient T-1 comparison; GFR; delayed enhancement; GLOMERULAR-FILTRATION-RATE; DELAYED-ENHANCEMENT; CONTRAST; MRI; ATHEROSCLEROSIS; VISUALIZATION; INJECTION; EXTENT; BLOOD; TIME;
D O I
10.1002/mrm.22716
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Quantitative T-1 mapping of delayed gadolinium-enhanced cardiac magnetic resonance imaging has shown promise in identifying diffuse myocardial fibrosis. Despite careful control of magnetic resonance imaging parameters, comparison of T-1 times between different patients may be problematic because of patient specific factors such as gadolinium dose, differing glomerular filtration rates, and patient specific delay times. In this work, a model driven approach to account for variations between patients to allow for comparison of T-1 data is provided. Kinetic model parameter values were derived from healthy volunteer time-contrast curves. Correction values for the factors described above were used to normalize T-1 values to a matched state. Examples of pre- and postcorrected values for a pool of normal subjects and in a patient cohort of type 1 diabetic patients shows tighter clustering and improved discrimination of disease state. Magn Reson Med 65:1407-1415, 2011. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1407 / 1415
页数:9
相关论文
共 33 条
  • [1] Standards of Medical Care in Diabetes-2009
    不详
    [J]. DIABETES CARE, 2009, 32 : S13 - S61
  • [2] Multi-ethnic study of atherosclerosis: Objectives and design
    Bild, DE
    Bluemke, DA
    Burke, GL
    Detrano, R
    Roux, AVD
    Folsom, AR
    Greenland, P
    Jacobs, DR
    Kronmal, R
    Liu, K
    Nelson, JC
    O'Leary, D
    Saad, MF
    Shea, S
    Szklo, M
    Tracy, RP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) : 871 - 881
  • [3] Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements:: A phase I trial
    Boss, Andreas
    Martirosian, Petros
    Gehrmann, Michael
    Artunc, Ferruh
    Risler, Teut
    Oesingmann, Niels
    Claussen, Claus D.
    Schick, Fritz
    Kueper, Klaus
    Schlemmer, Heinz-Peter
    [J]. RADIOLOGY, 2007, 242 (03) : 783 - 790
  • [4] Delaney JAC, 2009, CAN J CARDIOL, V25, pE232
  • [5] Foley RN, 1998, J AM SOC NEPHROL, V9, P267
  • [6] Clinical epidemiology of cardiovascular disease in chronic renal disease
    Foley, RN
    Parfrey, PS
    Sarnak, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : S112 - S119
  • [7] Genuth S, 1999, DIABETES CARE, V22, P99
  • [8] Genuth S, 2007, NEW ENGL J MED, V356, P1842
  • [9] Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current applications and future perspectives
    Gottlieb, Ilan
    Macedo, Robson
    Bluemke, David A.
    Lima, Joao A. C.
    [J]. HEART FAILURE REVIEWS, 2006, 11 (04) : 313 - 323
  • [10] Gadobutrol, a highly concentrated MR-imaging contrast agent,agent its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging
    Huppertz, A
    Rohrer, M
    [J]. EUROPEAN RADIOLOGY, 2004, 14 : M12 - M18